How Parathyroid Hormone Affects Bone Growth in Mice
Author Information
Author(s): Kramer Ina, Loots Gabriela G, Studer Anne, Keller Hansjoerg, Kneissel Michaela
Primary Institution: Novartis Institutes for BioMedical Research
Hypothesis
Suppression of the bone formation inhibitor Sost by intermittent PTH treatment contributes to PTH bone anabolism.
Conclusion
PTH-induced bone gain is reduced in mice that overexpress or lack Sost.
Supporting Evidence
- PTH treatment significantly increased total BMD in wild-type mice but not in SOST Tg mice.
- SOST Tg mice showed a 50% reduction in PTH-induced bone gain compared to wild-type mice.
- Bone formation rates were significantly lower in SOST Tg mice after PTH treatment.
- Homozygous Sost KO mice did not show significant bone gain in response to PTH treatment.
Takeaway
When mice get a hormone called PTH, it usually helps their bones grow. But if they have too much or too little of a certain protein called Sost, this growth doesn't happen as well.
Methodology
Mice with altered Sost gene dosage were treated with PTH and their bone changes were analyzed using various imaging techniques.
Limitations
The study was conducted on genetically modified mice, which may not fully represent human physiology.
Participant Demographics
Six-month-old Sost overexpressing and two-month-old Sost deficient male mice were used.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website